We heard from our healthcare forum panelists that innovation is the table stakes for success in the medical products industry in today’s changing environment. Drug-device combination products are at the forefront of innovation. But today, the well-known drug‐eluting stents are no longer the only innovative combination product creating new markets and capturing market share. Scientists and marketers are bringing biologics (cells) into the mix, among other things, and the possibilities are now endless, and exciting.
Come learn about new technologies and the marketing and development challenges facing them from a distinguished panel of industry leaders from om Boston Scientific, Covidien, Sanofi-Aventis and Biogen-Idec. Maria Shepherd, president of Data Decision Group, will present trends and moderate this thought provoking panel discussion.